Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too [TechCrunch]
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total
Read moreJust three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total
Read moreHarry Destecroix co-founded Ziylo while studying for his PhD at the University of Bristol. Ziylo, a university spin-out company, developed
Read moreFor Quantum cryptography and simulation to become real, the technology requires high-performance light-emitting and light-detecting components that operate at the
Read more